Clinical Trial Update: Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing neural changes after anticholinergic, beta-3 agonist, or placebo in patients with overactive bladder

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Incontinence Urge
• Lower Urinary Tract Symptoms
• Overactive Bladder

Snippet

Sponsor: Baylor Research Institute | Conditions: Overactive Bladder, Dementia | Phase 4 | Status: COMPLETED